Re: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy plus Short-term Androgen Deprivation Therapy in Men with Localised Prostate Cancer After Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 Trial

被引：0
|
作者：
Rodriguez-Sanchez, Lara [1 ]
Crehangec, Gilles [3 ,4 ]
Bennamoun, Mostefa [5 ]
Macek, Petr [2 ]
Cathelineau, Xavier [2 ]
Sanchez-Salas, Rafael [2 ]
机构：
[1] Hosp Univ Miguel Servet, Dept Urol, Zaragoza, Spain
[2] Inst Mutualiste Montsouris, Dept Urol, 42 Blvd Jourdan, F-75014 Paris, France
[3] Inst Curie, Dept Radiat Oncol, Paris, France
[4] Inst Mutualiste Montsouris, Dept Radiat Oncol, Paris, France
[5] Inst Mutualiste Montsouris, Dept Med Oncol, Paris, France
来源：
EUROPEAN UROLOGY | 2021年 / 79卷 / 04期
关键词：
RISK;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：555 / 556
页数：2
相关论文
共 50 条
  • [1] Re: Adjuvant Radiotherapy versus Early Salvage Radiotherapy plus Short-Term Androgen Deprivation Therapy in Men with Localised Prostate Cancer after Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 Trial
    不详
    [J]. JOURNAL OF UROLOGY, 2021, 205 (04): : 1225 - 1225
  • [2] Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
    Sargos, Paul
    Chabaud, Sylvie
    Latorzeff, Igor
    Magne, Nicolas
    Benyoucef, Ahmed
    Supiot, Stephane
    Pasquier, David
    Abdiche, Menouar Samar
    Gilliot, Olivier
    Graff-Cailleaud, Pierre
    Silva, Marlon
    Bergerot, Philippe
    Baumann, Pierre
    Belkacemi, Yazid
    Azria, David
    Brihoum, Meryein
    Soulie, Michel
    Richaud, Pierre
    [J]. LANCET ONCOLOGY, 2020, 21 (10): : 1341 - 1352
  • [3] Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
    Carrie, Christian
    Magne, Nicolas
    Burban-Provost, Patricia
    Sargos, Paul
    Latorzeff, Igor
    Lagrange, Jean-Leon
    Supiot, Stephane
    Belkacemi, Yazid
    Peiffert, Didier
    Allouache, Nedla
    Dubray, Bernard M.
    Servagi-Vernat, Stephanie
    Suchaud, Jean-Philippe
    Crehange, Gilles
    Guerif, Stephane
    Brihoum, Meryem
    Barbier, Nicolas
    Graff-Cailleaud, Pierre
    Ruffion, Alain
    Dussart, Sophie
    Ferlay, Celine
    Chabaud, Sylvie
    [J]. LANCET ONCOLOGY, 2019, 20 (12): : 1740 - 1749
  • [4] A Phase III Randomized Trial Comparing Adjuvant versus Early Salvage Radiotherapy, Both Combined with Short-term Androgen Deprivation Therapy, following a Radical Prostatectomy: Initial Results of the GETUG-AFU 17 Study [NCT00667069]
    Sargos, P.
    Chabaud, S.
    Latorzeff, I.
    Magne, N.
    Benyoucef, A.
    Supiot, S.
    Pasquier, D.
    Abdiche, S.
    Gilliot, O.
    Graff, P.
    Silva, M.
    Bergerot, P.
    Baumann, P.
    Belkacemi, Y.
    Azria, D.
    Nenan, S.
    Richaud, P. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S17 - S18
  • [5] Comparative Effectiveness of Radical Prostatectomy With Adjuvant Radiotherapy Versus Radiotherapy Plus Androgen Deprivation Therapy for Men With Advanced Prostate Cancer
    Jang, Thomas L.
    Patel, Neal
    Faiena, Izak
    Radadia, Kushan D.
    Moore, Dirk F.
    Elsamra, Sammy E.
    Singer, Eric A.
    Stein, Mark N.
    Eastham, James A.
    Scardino, Peter T.
    Lin, Yong
    Kim, Isaac Y.
    Lu-Yao, Grace L.
    [J]. CANCER, 2018, 124 (20) : 4010 - 4022
  • [6] Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
    Carrie, Christian
    Hasbini, Ali
    de Laroche, Guy
    Richaud, Pierre
    Guerif, Stephane
    Latorzeff, Igor
    Supiot, Stephane
    Bosset, Mathieu
    Lagrange, Jean-Leon
    Beckendorf, Veronique
    Lesaunier, Francois
    Dubray, Bernard
    Wagner, Jean-Philippe
    Tan Dat N'Guyen
    Suchaud, Jean-Philippe
    Crehange, Gilles
    Barbier, Nicolas
    Habibian, Muriel
    Ferlay, Celine
    Fourneret, Philippe
    Ruffion, Alain
    Dussart, Sophie
    [J]. LANCET ONCOLOGY, 2016, 17 (06): : 747 - 756
  • [7] Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy
    Yoo, Sangjun
    You, Dalsan
    Kim, Young Seok
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    [J]. UROLOGIA INTERNATIONALIS, 2017, 99 (04) : 406 - 413
  • [8] Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial (vol 17, pg 747, 2016)
    Carrie, C.
    Hasbini, A.
    de Laroche, G.
    [J]. LANCET ONCOLOGY, 2019, 20 (06): : E293 - E293
  • [9] Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. (vol 17, pg 747, 2016)
    Carrie, C.
    Hasbini, A.
    de Laroche, G.
    [J]. LANCET ONCOLOGY, 2016, 17 (06): : E223 - E223
  • [10] RADICAL PROSTATECTOMY WITH ADJUVANT RADIOTHERAPY VERSUS ANDROGEN DEPRIVATION THERAPY PLUS RADIOTHERAPY FOR ADVANCED, NON-DISTANT METASTATIC PROSTATE CANCER
    Jang, Thomas
    Patel, Neal
    Shen, Shunhua
    DiPaola, Robert
    Moore, Dirk
    Kim, Isaac
    Lu-Yao, Grace
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E896 - E897
12345